Michael John Sumner - 15 May 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
15 May 2023
Net transactions value
$0
Form type
4
Filing time
17 May 2023, 16:12:39 UTC
Previous filing
28 Feb 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +85,878 $0.000000 85,878 15 May 2023 Common Stock 85,878 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 This grant was made under the 2016 Omnibus Incentive Plan.